{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:55:48Z","timestamp":1761252948315},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,21]],"date-time":"2014-12-21T00:00:00Z","timestamp":1419120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10549-014-3244-8","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T02:52:25Z","timestamp":1419043945000},"page":"343-351","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer"],"prefix":"10.1007","volume":"149","author":[{"given":"Jan J.","family":"Jobsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job","family":"van der Palen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00ebl","family":"Brinkhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan W. R.","family":"Nortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"Struikmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,21]]},"reference":[{"key":"3244_CR1","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","volume":"124","author":"PL Fitzgibbons","year":"2000","unstructured":"Fitzgibbons PL, Page KL, Weaver D et al (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966\u2013975","journal-title":"Arch Pathol Lab Med"},{"key":"3244_CR2","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1200\/JCO.2005.05.511","volume":"23","author":"JPA Baak","year":"2005","unstructured":"Baak JPA, van Diest PJ, Voorhorst FJ et al (2005) Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55\u00a0years. J Clin Oncol 23:5993\u20136001","journal-title":"J Clin Oncol"},{"key":"3244_CR3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2009.25.0407","volume":"29","author":"TH Lende","year":"2011","unstructured":"Lende TH, Janssen EAM, Gudlaugsson E et al (2011) In patients younger than age 55\u00a0years with lymph node-negative breast cancer, proliferation by mitotic activity is prognostically superior to adjuvant. J Clin Oncol 29:852\u2013858","journal-title":"J Clin Oncol"},{"key":"3244_CR4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.humpath.2007.08.016","volume":"39","author":"I Skaland","year":"2008","unstructured":"Skaland I, van Diest PJ, Janssen EAM et al (2008) Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55\u00a0years. Hum Pathol 39:584\u2013590","journal-title":"Hum Pathol"},{"key":"3244_CR5","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/ijc.21623","volume":"118","author":"WJ Louwman","year":"2006","unstructured":"Louwman WJ, van Beek MWPM, Schapers RFM et al (2006) Long-term survival of T1 and T2 lymph node-negative breast cancer patients according to mitotic activity index: a population-based study. Int J Cancer 118:2310\u20132314","journal-title":"Int J Cancer"},{"key":"3244_CR6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.MP.0000093625.20366.9D","volume":"16","author":"L Medri","year":"2003","unstructured":"Medri L, Volpi A, Nanni O et al (2003) Prognostic relevance of mitotic activity in patients with node-negative breast cancer. Mod Pathol 16:1067\u20131075","journal-title":"Mod Pathol"},{"key":"3244_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cncr.11916","volume":"100","author":"JJ Michels","year":"2004","unstructured":"Michels JJ, Marnay J, Delozier T et al (2004) Proliferative activity in primary breast carcinomas is a salient prognostic factor. Cancer 100:455\u2013464","journal-title":"Cancer"},{"key":"3244_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-009-0442-x","volume":"121","author":"E Gudlaugsson","year":"2010","unstructured":"Gudlaugsson E, Skaland I, Janssen EAM et al (2010) Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer. Breast Cancer Res Treat 121:35\u201340","journal-title":"Breast Cancer Res Treat"},{"key":"3244_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-008-0126-y","volume":"115","author":"JPA Baak","year":"2009","unstructured":"Baak JPA, Gudlaugsson E, Skaland I et al (2009) Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Res Treat 115:241\u2013254","journal-title":"Breast Cancer Res Treat"},{"key":"3244_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/annonc\/mdm535","volume":"19","author":"JP Baak","year":"2008","unstructured":"Baak JP, van Diest PJ, Janssen EA et al (2008) Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers. Ann Oncol 19:649\u2013654","journal-title":"Ann Oncol"},{"key":"3244_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejca.2006.10.001","volume":"43","author":"JP Baak","year":"2007","unstructured":"Baak JP, van Diest PJ, Voorhorst FJ et al (2007) The prognostic value of proliferation in lymph node-negative breast cancer patients is age dependent. Eur J Cancer 43:527\u2013535","journal-title":"Eur J Cancer"},{"key":"3244_CR12","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ejca.2005.03.038","volume":"41","author":"JP Baak","year":"2005","unstructured":"Baak JP, Colpaert CG, van Diest PJ et al (2005) Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers. Eur J Cancer 41:2093\u20132101","journal-title":"Eur J Cancer"},{"key":"3244_CR13","first-page":"571","volume":"18","author":"C Genestie","year":"1998","unstructured":"Genestie C, Zafrani B, Asselain B et al (1998) Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res 18:571\u2013576","journal-title":"Anticancer Res"},{"key":"3244_CR14","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G","volume":"64","author":"V Doussal Le","year":"1989","unstructured":"Le Doussal V, Tubiana-Hulin M, Friedman S et al (1989) Prognostic value of histological grade nuclear components of Scarff-Bloom-Richardson. An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64:1914\u20131921","journal-title":"Cancer"},{"key":"3244_CR15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/jcp.2003.010777","volume":"57","author":"PJ Diest Van","year":"2004","unstructured":"Van Diest PJ, van der Wall E, Baak JPA (2004) Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 57:675\u2013681","journal-title":"J Clin Pathol"},{"key":"3244_CR16","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early breast Cancer 2013. Ann Oncol 24:2206\u20132223","journal-title":"Ann Oncol"},{"key":"3244_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2666-z","volume":"141","author":"JJ Carlson","year":"2013","unstructured":"Carlson JJ, Roth JA (2013) The impact on the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis. Breast Cancer Res Treat 141:13\u201322","journal-title":"Breast Cancer Res Treat"},{"key":"3244_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors for breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403\u2013410","journal-title":"Histopathology"},{"key":"3244_CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejso.2004.08.012","volume":"31","author":"WE Fiets","year":"2005","unstructured":"Fiets WE, Bellot FE, Struikmans H et al (2005) Prognostic value of mitotic count in axillary node negative breast cancer patients with predominantly well-differentiated tumours. EJSO 31:128\u2013133","journal-title":"EJSO"},{"key":"3244_CR20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/modpathol.3800161","volume":"17","author":"A Volpi","year":"2004","unstructured":"Volpi A, Bacci F, Pardiso A et al (2004) Prognostic relevance of histological grade and its components in node-negative breast cancer patients. Mod Pathol 17:1038\u20131044","journal-title":"Mod Pathol"},{"key":"3244_CR21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3322\/canjclin.47.1.28","volume":"47","author":"WL Donegan","year":"1997","unstructured":"Donegan WL (1997) Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47:28\u201351","journal-title":"CA Cancer J Clin"},{"key":"3244_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-200201000-00003","volume":"235","author":"AN Mirza","year":"2002","unstructured":"Mirza AN, Mirza NQ, Vlastos G et al (2002) Prognostic factors in node-negative breast cancer. A review of studies with sample size more than 200 and follow-up more than 5\u00a0years. Ann Surg 235:10\u201326","journal-title":"Ann Surg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3244-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3244-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3244-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T18:03:04Z","timestamp":1650823384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3244-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,21]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3244"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3244-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,21]]}}}